Thomas discussed such a move at the beginning of the discussion of the $243 million disease team round. Nine out of 15 rejected applicants have appealed to the full board. Some have presented new information. Others have disputed the scientific work of reviewers.
The board used such a referral process for one application in the past. That grant was ultimately approved.
No comments:
Post a Comment